AU2013211651C1 - Use of lysozyme as a tag - Google Patents

Use of lysozyme as a tag Download PDF

Info

Publication number
AU2013211651C1
AU2013211651C1 AU2013211651A AU2013211651A AU2013211651C1 AU 2013211651 C1 AU2013211651 C1 AU 2013211651C1 AU 2013211651 A AU2013211651 A AU 2013211651A AU 2013211651 A AU2013211651 A AU 2013211651A AU 2013211651 C1 AU2013211651 C1 AU 2013211651C1
Authority
AU
Australia
Prior art keywords
lysozyme
protein
polypeptide
amino acids
tag
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2013211651A
Other languages
English (en)
Other versions
AU2013211651A1 (en
AU2013211651B2 (en
Inventor
Daniela Daubert
Stefan HAERTLE
Sebastian Jaeger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Morphosys GmbH
Original Assignee
Morphosys GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Morphosys GmbH filed Critical Morphosys GmbH
Publication of AU2013211651A1 publication Critical patent/AU2013211651A1/en
Application granted granted Critical
Publication of AU2013211651B2 publication Critical patent/AU2013211651B2/en
Publication of AU2013211651C1 publication Critical patent/AU2013211651C1/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/35—Fusion polypeptide containing a fusion for enhanced stability/folding during expression, e.g. fusions with chaperones or thioredoxin

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2013211651A 2012-01-23 2013-01-23 Use of lysozyme as a tag Ceased AU2013211651C1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261589408P 2012-01-23 2012-01-23
EP12152095 2012-01-23
US61/589,408 2012-01-23
EP12152095.1 2012-01-23
PCT/EP2013/051181 WO2013110627A1 (en) 2012-01-23 2013-01-23 Use of lysozyme as a tag

Publications (3)

Publication Number Publication Date
AU2013211651A1 AU2013211651A1 (en) 2014-07-24
AU2013211651B2 AU2013211651B2 (en) 2017-03-02
AU2013211651C1 true AU2013211651C1 (en) 2017-10-12

Family

ID=48872896

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2013211651A Ceased AU2013211651C1 (en) 2012-01-23 2013-01-23 Use of lysozyme as a tag

Country Status (10)

Country Link
US (1) US9689014B2 (enExample)
EP (1) EP2807179B1 (enExample)
JP (1) JP6215231B2 (enExample)
KR (1) KR20140122729A (enExample)
CN (1) CN104066745B (enExample)
AU (1) AU2013211651C1 (enExample)
CA (1) CA2860916A1 (enExample)
ES (1) ES2582802T3 (enExample)
IN (1) IN2014DN06660A (enExample)
WO (1) WO2013110627A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105524942A (zh) * 2016-02-05 2016-04-27 广州赛莱拉干细胞科技股份有限公司 一种表达载体及胰岛素样生长因子结合蛋白3的表达方法
AU2017384228B2 (en) * 2016-12-21 2024-07-25 Novozymes A/S Polypeptides having lysozyme activity, polynucleotides encoding same and uses and compositions thereof
AU2017380488B2 (en) 2016-12-21 2023-09-14 Novozymes A/S Polypeptides having lysozyme activity, polynucleotides encoding same and uses and compositions thereof
CN107794254A (zh) * 2017-09-30 2018-03-13 昆明理工大学 重组高温裂解酶的快速纯化方法
US20240034961A1 (en) * 2020-12-16 2024-02-01 Danisco Us Inc Enzymes and enzyme compositions for cleaning
EP4486858A1 (en) * 2022-03-01 2025-01-08 Danisco US Inc. Enzymes and enzyme compositions for cleaning
WO2025179145A1 (en) * 2024-02-23 2025-08-28 Dualitas Therapeutics, Inc. Bispecific screening compositions and methods

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001000855A1 (en) * 1999-06-23 2001-01-04 Ppl Therapeutics (Scotland) Ltd. Fusion proteins incorporating lysozyme
US7790850B2 (en) * 2007-10-17 2010-09-07 The Board Of Trustees Of The Leland Stanford Junior University Method and composition for crystallizing G protein-coupled receptors

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2459701A (en) 1945-07-16 1949-01-18 Harper Esther Pardee Mechanical instrument holder
US4355022A (en) 1981-07-01 1982-10-19 Interon, Inc. Method of dental treatment
JP2761881B2 (ja) * 1988-03-10 1998-06-04 チッソ株式会社 抗体を固定化したアフイニテイクロマトグラフイ用担体
EP0425016B1 (en) 1989-10-27 1995-12-20 The Procter & Gamble Company Antimicrobial method and formulation employing type II endoglycosidase and antimicrobial agent
DE59812393D1 (de) 1997-08-22 2005-01-20 Siemens Ag Verfahren zur klopfregelung einer brennkraftmaschine
KR20010089301A (ko) 1998-10-15 2001-09-29 윌리암 로엘프 드 보에르 동물 사료에서 항미생물 효소
DE60318014T2 (de) 2002-01-07 2008-11-27 Lifesensors, Inc. Verfahren und zusammensetzungen für die proteinexpression und reinigung
DE10237317B4 (de) 2002-08-15 2010-04-08 3M Espe Ag Enzymhaltige Zusammensetzung, Verfahren zu deren Herstellung und deren Verwendung
CA2404356A1 (en) 2002-09-18 2004-03-18 Canadian Inovatech Inc. Gram-positive antibacterial composition and method for use
US7428273B2 (en) 2003-09-18 2008-09-23 Promptu Systems Corporation Method and apparatus for efficient preamble detection in digital data receivers
JP4891220B2 (ja) 2004-02-25 2012-03-07 ノボザイムス アクティーゼルスカブ 菌類細胞壁分解酵素
US8119600B2 (en) 2007-04-10 2012-02-21 Stefano Ferrari Compositions containing lysozyme and C-1/C-4 polysaccharides and use thereof in oral care, cosmetology and dermatology, contraception, urology and gynecology
CN101817883B (zh) * 2010-03-12 2012-06-13 广东药学院 一种家蝇天蚕素-人溶菌酶融合蛋白及其制备方法和应用

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001000855A1 (en) * 1999-06-23 2001-01-04 Ppl Therapeutics (Scotland) Ltd. Fusion proteins incorporating lysozyme
US7790850B2 (en) * 2007-10-17 2010-09-07 The Board Of Trustees Of The Leland Stanford Junior University Method and composition for crystallizing G protein-coupled receptors

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
HEARN M.T.W. et al., "Evaluation of factors which affect column performance with immobilized monoclonal antibodies: Model studies with a lysozyme-antilysozyme system", Journal of Chromatography A, 1990, Volume 512, *
SMITH-GILL S.J. et al., "A Three-dimensional Model of an Anti-lysozyme Antibody", Journal of Molecular Biology, 1987, Vol. 194, No. 4, pages 713-724 *

Also Published As

Publication number Publication date
JP6215231B2 (ja) 2017-10-18
KR20140122729A (ko) 2014-10-20
CA2860916A1 (en) 2013-08-01
AU2013211651A1 (en) 2014-07-24
EP2807179B1 (en) 2016-04-20
WO2013110627A1 (en) 2013-08-01
AU2013211651B2 (en) 2017-03-02
US9689014B2 (en) 2017-06-27
ES2582802T3 (es) 2016-09-15
HK1202298A1 (en) 2015-09-25
EP2807179A1 (en) 2014-12-03
CN104066745A (zh) 2014-09-24
US20140349343A1 (en) 2014-11-27
CN104066745B (zh) 2017-04-12
IN2014DN06660A (enExample) 2015-05-22
JP2015504683A (ja) 2015-02-16

Similar Documents

Publication Publication Date Title
AU2013211651B2 (en) Use of lysozyme as a tag
CN109593126B (zh) 多肽、其生产方法和用途
Zuo et al. Enhanced expression and purification of membrane proteins by SUMO fusion in Escherichia coli
WO2024087784A1 (zh) 酵母重组xvii型人源化胶原蛋白及其制备方法
KR102865788B1 (ko) 생합성 인체구조성 재료의 제조방법
JP6728294B2 (ja) たんぱく質精製の新規な方法
CN103374579A (zh) 一种菌丝霉素及其基因和制备方法
Davies et al. Recombinant baculovirus vectors expressing glutathione–S–transferase fusion proteins
CN107446941A (zh) 基于自聚集短肽诱导的天蚕素a抗菌肽及其制备方法
CN105316353A (zh) 一种利用碱性标签和内含肽融合表达纯化重组蛋白的方法
CN117625656A (zh) 一种sumo蛋白酶基因、重组表达载体、工程菌及其应用
CN114196688A (zh) 在酵母中表达原核碱性磷酸酶
WO2016186575A1 (en) Native protein purification technology
HK1202298B (en) Use of lysozyme as a tag
US8916154B2 (en) Antibodies against delta-5 desaturase and uses thereof
US20200385774A1 (en) Peptide sequence of a guide protein for the production of a peptide of interest, an expression vector, a host cell, and a method for the production of a peptide of interest
CN108753758B (zh) 超嗜热脂肪酶LipL及其相关生物材料与应用
CN108841804B (zh) 超嗜热脂肪酶LipH及其相关生物材料与应用
CN102190730A (zh) 一种生物素蛋白连接酶融合蛋白
CN112941058A (zh) 一种重组溶组织梭菌ii型胶原酶及其制备方法和应用
US20030170615A1 (en) Peptide tag for monitoring and purification of proteins
KR101505697B1 (ko) 시스토바이러스 파이12의 외피막 단백질 피9을 융합파트너로 포함하는 막 단백질 발현벡터 및 이를 이용한 막 단백질 제조 방법
CN105112382B (zh) 一种基于家蚕-杆状病毒系统制备人髓过氧化物酶的方法
CN108753757B (zh) 超嗜热脂肪酶LipP及其相关生物材料与应用
CN108753756B (zh) 超嗜热脂肪酶LipD及其相关生物材料与应用

Legal Events

Date Code Title Description
DA2 Applications for amendment section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 09 MAY 2017

TH Corrigenda

Free format text: IN VOL 31 , NO 28 , PAGE(S) 4164 UNDER THE HEADING AMENDMENTS - APPLICATION FOR AMENDMENTS UNDER THE NAME MORPHOSYS AG, APPLICATION NO. 2013211651 CORRECT THE DATE OF THE STATEMENTS FILED TO READ 09 MAY 2017 AND 07 JUL 2017

DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 09 MAY 2017 AND 07 JUL 2017

FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired